<DOC>
	<DOCNO>NCT00935597</DOCNO>
	<brief_summary>The purpose study assess preliminary efficacy determine safety feasibility ex vivo generate dendritic cell ( HDC ) infusion without donor lymphocyte infusion ( DLI ) allogeneic stem cell transplant ( SCT ) . We also wish establish feasibility apheresis shipment well vaccine shipment stability population .</brief_summary>
	<brief_title>Host Dendritic Cells Allograft Patients</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Age 1870 Ability sign inform consent ECOG performance status ≤3 Life expectancy &gt; 6 month Adequate cardiac function : MUGA Echocardiogram demonstrate &gt; 50 % Ejection Fraction Adequate pulmonary function DLCO &gt; 50 % Adequate hepatic function Bilirubin ≤ 1.5mg/dl Alkaline phosphatase ≤5 time upper limit normal Aspartate aminotransferase ( AST ) serum glutamicoxaloacetic transferase ( SGOT ) ≤ 3 time upper limit normal Alanine aminotransferase ( ALT ) serum glutamic pyruvic transaminase ( SGPT ) ≤ 3 time upper limit normal Adequate renal function Estimated creatinine clearance &gt; 40ml/min Diagnosis one follow NonHodgkin 's lymphoma exclude Follicular lymphoma Marginal Zone Lymphoma Hodgkin 's lymphoma Multiple myeloma Chronic lymphocytic leukemia Eligible allogeneic stem cell transplant identify HLAidentical sibling ( 6/6 HLA match ) volunteer unrelated donor ( 8/8 allele HLAmatched ( A , B , Cw , DRB1 ) Women childbearing potential must negative serum pregnancy test prior enrollment Women childbearing potential must use effective mean birth control throughout study . Men father child enrol study . Effective mean birth control include condom , vasectomy abstinence . Malignancies melanoma within five year study entry , except carcinoma insitu cervix basal/squamous cell skin cancer Concurrent illness would preclude survival &gt; 6 month disease study Pregnancy nursing HIV infection Treatment prior donor lymphocyte infusion Prior allogeneic stem cell transplant History autoimmune disease include systemic lupus erythematosus , rheumatoid arthritis thyroiditis Active infection include fungal infection viral hepatitis GVHD great grade I GVHD skin Patient Exclusion Criteria Part B ( post Stem Cell Transplant ) Malignancies melanoma within five year study entry , except carcinoma insitu cervix basal/squamous cell skin cancer Concurrent illness would preclude survival &gt; 6 month disease study . Pregnancy nurse HIV infection Treatment prior donor lymphocyte infusion Prior allogeneic stem cell transplant More 4 prior relapse History autoimmune disease include systemic lupus erythematosus , rheumatoid arthritis thyroiditis Active infection include fungal infection viral hepatitis GVHD great grade I GVHD skin No cytotoxics give within 4 week administration investigational cell therapy Patients receive investigational agent within 30 day prior administration investigational cell therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Relapsed Non-Hodgkin 's Lymphoma</keyword>
	<keyword>Hodgkin 's Disease</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Chronic Lymphocytic Lymphoma</keyword>
	<keyword>Relapsed Non-Hodgkin 's lymphoma ( exclude follicular lymphoma marginal zone lymphoma )</keyword>
</DOC>